ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 223 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,130,009 | +2.4% | 314,308 | -1.8% | 0.00% | 0.0% |
| Q2 2023 | $4,033,461 | -3.1% | 320,116 | +0.4% | 0.00% | 0.0% |
| Q1 2023 | $4,161,306 | -25.0% | 318,874 | +1.4% | 0.00% | -50.0% |
| Q4 2022 | $5,548,749 | +15.4% | 314,555 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $4,809,000 | -5.2% | 315,743 | -7.7% | 0.00% | 0.0% |
| Q2 2022 | $5,072,000 | -37.1% | 342,044 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $8,069,000 | +20.6% | 358,331 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $6,691,000 | +38.1% | 362,671 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $4,845,000 | -37.9% | 362,415 | -14.1% | 0.00% | -33.3% |
| Q2 2021 | $7,807,000 | +0.7% | 421,836 | -18.3% | 0.00% | 0.0% |
| Q1 2021 | $7,750,000 | -1.7% | 516,123 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $7,884,000 | +72.6% | 545,952 | -2.7% | 0.00% | +50.0% |
| Q3 2020 | $4,568,000 | +20.6% | 561,138 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $3,789,000 | +110.1% | 559,613 | +118.5% | 0.00% | +100.0% |
| Q1 2020 | $1,803,000 | -27.6% | 256,151 | +0.9% | 0.00% | 0.0% |
| Q4 2019 | $2,492,000 | -2.2% | 253,841 | +9.5% | 0.00% | 0.0% |
| Q3 2019 | $2,547,000 | -1.2% | 231,896 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $2,578,000 | +20.6% | 221,639 | -1.1% | 0.00% | 0.0% |
| Q1 2019 | $2,138,000 | -0.1% | 224,042 | +0.9% | 0.00% | -50.0% |
| Q4 2018 | $2,141,000 | -30.8% | 222,124 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $3,093,000 | +17.6% | 217,055 | -1.0% | 0.00% | 0.0% |
| Q2 2018 | $2,631,000 | -11.8% | 219,304 | -9.2% | 0.00% | 0.0% |
| Q1 2018 | $2,983,000 | -15.7% | 241,568 | -0.6% | 0.00% | -33.3% |
| Q4 2017 | $3,538,000 | +6.0% | 243,123 | +3.7% | 0.00% | 0.0% |
| Q3 2017 | $3,337,000 | +38.7% | 234,439 | +24.4% | 0.00% | +50.0% |
| Q2 2017 | $2,406,000 | -5.9% | 188,485 | -6.5% | 0.00% | 0.0% |
| Q1 2017 | $2,557,000 | +80.7% | 201,689 | +45.7% | 0.00% | +100.0% |
| Q4 2016 | $1,415,000 | -6.8% | 138,449 | +20.0% | 0.00% | -50.0% |
| Q3 2016 | $1,519,000 | +7.6% | 115,399 | +3.7% | 0.00% | +100.0% |
| Q2 2016 | $1,412,000 | +7.3% | 111,270 | +11.7% | 0.00% | 0.0% |
| Q1 2016 | $1,316,000 | +2.7% | 99,651 | +19.6% | 0.00% | 0.0% |
| Q4 2015 | $1,281,000 | +157.7% | 83,299 | +108.1% | 0.00% | 0.0% |
| Q3 2015 | $497,000 | -25.7% | 40,027 | -18.2% | 0.00% | 0.0% |
| Q2 2015 | $669,000 | +46.1% | 48,953 | +27.9% | 0.00% | 0.0% |
| Q1 2015 | $458,000 | +563.8% | 38,276 | +611.1% | 0.00% | – |
| Q4 2014 | $69,000 | -4.2% | 5,383 | 0.0% | 0.00% | – |
| Q3 2014 | $72,000 | -16.3% | 5,383 | 0.0% | 0.00% | – |
| Q2 2014 | $86,000 | – | 5,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |